肾素-血管紧张素系统与代谢综合征
The renin angiotensin system and the metabolic syndrome.
作者信息
Wang Chih-Hong, Li Feng, Takahashi Nobuyuki
机构信息
Department of Pathology and Laboratory Medicine The University of North Carolina at Chapel Hill Chapel Hill, NC 27599-7525.
出版信息
Open Hypertens J. 2010;3:1-13. doi: 10.2174/1876526203010001.
Abstract
The renin angiotensin system (RAS) is important for fluid and blood pressure regulation. Recent studies suggest that an overactive RAS is involved in the metabolic syndrome. This article discusses recent advances on how genetic alteration of the RAS affects cardiovascular and metabolic phenotypes, with a special emphasis on the potential role of angiotensin-independent effects of renin.
摘要
肾素血管紧张素系统（RAS）对体液和血压调节至关重要。最近的研究表明，过度活跃的RAS与代谢综合征有关。本文讨论了RAS基因改变如何影响心血管和代谢表型的最新进展，特别强调了肾素非血管紧张素依赖性效应的潜在作用。
相似文献
1
The renin angiotensin system and the metabolic syndrome.
Open Hypertens J. 2010;3:1-13. doi: 10.2174/1876526203010001.
2
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Peptides. 2011 Jul;32(7):1551-65. doi: 10.1016/j.peptides.2011.05.012. Epub 2011 Jun 14.
3
[Network regulation of renin-angiotensin system on the cardiovascular diseases].
Sheng Li Ke Xue Jin Zhan. 2013 Jun;44(3):183-7.
4
Intratubular and intracellular renin-angiotensin system in the kidney: a unifying perspective in blood pressure control.
Clin Sci (Lond). 2018 Jul 9;132(13):1383-1401. doi: 10.1042/CS20180121. Print 2018 Jul 16.
5
The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.
Clin Auton Res. 2019 Apr;29(2):231-243. doi: 10.1007/s10286-018-0572-5. Epub 2018 Nov 9.
6
Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue.
Compr Physiol. 2017 Sep 12;7(4):1137-1150. doi: 10.1002/cphy.c160031.
7
Megalin-Mediated Endocytosis in the Kidney Proximal Tubule: Relevance to Regulation of the Renal Renin-Angiotensin System.
Nephron. 2023;147(3-4):244-249. doi: 10.1159/000526369. Epub 2022 Sep 12.
8
Recent Advances in Understanding the Molecular Pathophysiology of Angiotensin II Receptors: Lessons From Cell-Selective Receptor Deletion in Mice.
Can J Cardiol. 2023 Dec;39(12):1795-1807. doi: 10.1016/j.cjca.2023.06.421. Epub 2023 Jul 1.
9
Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.
Clin Exp Nephrol. 2012 Apr;16(2):214-20. doi: 10.1007/s10157-011-0568-0. Epub 2011 Dec 2.
10
The renin angiotensin system and the metabolic syndrome.
Physiol Behav. 2010 Jul 14;100(5):525-34. doi: 10.1016/j.physbeh.2010.03.018. Epub 2010 Apr 8.
引用本文的文献
1
Glucose Increases Hepatic Mitochondrial Antioxidant Enzyme Activities in Insulin Resistant Rats Following Chronic Angiotensin Receptor Blockade.
Int J Mol Sci. 2022 Sep 17;23(18):10897. doi: 10.3390/ijms231810897.
2
The gene knockout of angiotensin II type 1a receptor improves high-fat diet-induced obesity in rat via promoting adipose lipolysis.
PLoS One. 2022 Jul 8;17(7):e0267331. doi: 10.1371/journal.pone.0267331. eCollection 2022.
3
Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.
Metabolites. 2022 May 3;12(5):411. doi: 10.3390/metabo12050411.
4
The Crowded Uterine Horn Mouse Model for Examining Postnatal Metabolic Consequences of Intrauterine Growth Restriction vs. Macrosomia in Siblings.
Metabolites. 2022 Jan 22;12(2):102. doi: 10.3390/metabo12020102.
5
COVID's Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19.
Diabetes Metab Syndr Obes. 2020 Sep 11;13:3169-3192. doi: 10.2147/DMSO.S265518. eCollection 2020.
6
Antimetabolic Syndrome Effect of Phytosome Containing the Combined Extracts of Mulberry and Ginger in an Animal Model of Metabolic Syndrome.
Oxid Med Cell Longev. 2019 Nov 11;2019:5972575. doi: 10.1155/2019/5972575. eCollection 2019.
7
Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.
Med Arch. 2017 Aug;71(4):251-255. doi: 10.5455/medarh.2017.71.251-255.
8
Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade.
PLoS One. 2016 Dec 19;11(12):e0167704. doi: 10.1371/journal.pone.0167704. eCollection 2016.
9
The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
Int J Mol Med. 2015 May;35(5):1159-68. doi: 10.3892/ijmm.2015.2119. Epub 2015 Mar 2.
10
Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma.
Exp Ther Med. 2014 Feb;7(2):323-328. doi: 10.3892/etm.2013.1411. Epub 2013 Nov 15.
本文引用的文献
1
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
Circulation. 2009 Oct 20;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. Epub 2009 Oct 5.
2
Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes.
J Pharmacol Sci. 2009 Aug;110(4):459-65. doi: 10.1254/jphs.09115fp. Epub 2009 Aug 1.
3
eNOS, metabolic syndrome and cardiovascular disease.
Trends Endocrinol Metab. 2009 Aug;20(6):295-302. doi: 10.1016/j.tem.2009.03.005. Epub 2009 Jul 31.
4
Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006.
Natl Health Stat Report. 2009 May 5(13):1-7.
5
Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet.
Physiol Behav. 2009 Aug 4;98(1-2):192-7. doi: 10.1016/j.physbeh.2009.05.009. Epub 2009 May 22.
6
ACE insertion/deletion polymorphism and its relationships to the components of metabolic syndrome in elderly Slovaks.
Anthropol Anz. 2009 Mar;67(1):1-11.
7
Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):49-55. doi: 10.1016/j.numecd.2009.02.004. Epub 2009 Apr 9.
8
The kallikrein-kinin system in health and in diseases of the kidney.
Kidney Int. 2009 May;75(10):1019-30. doi: 10.1038/ki.2008.647. Epub 2009 Feb 4.
9
Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity?
Hypertension. 2009 Mar;53(3):516-23. doi: 10.1161/HYPERTENSIONAHA.108.124966. Epub 2009 Jan 26.
10
Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.
Pharmacotherapy. 2009 Feb;29(2):193-212. doi: 10.1592/phco.29.2.193.
Zotero 插件